By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ProSensa Holding N.V. 

Wassenaarseweg 72

Leiden    2333 AL  The Netherlands
Phone: 31-71-5274202 Fax: 31-71-5274203



Company News
ProSensa Holding N.V. (RNA) Announces 12 Presentations At The 19th International Congress Of The World Muscle Society In Berlin 9/9/2014 10:37:55 AM
ProSensa Holding N.V. (RNA) Announces Lancet Neurology Publication Of An Exploratory Phase 2 Study (DEMAND II) Demonstrating Efficacy And Safety Of Drisapersen In Patients With Duchenne Muscular Dystrophy 9/8/2014 7:15:15 AM
ProSensa Holding N.V. (RNA) Announces 2nd Quarter 2014 Financial Results And Recent Corporate Developments 8/12/2014 8:06:39 AM
ProSensa Holding N.V. (RNA) And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline 8/11/2014 4:28:22 PM
ProSensa Holding N.V. (RNA) To Webcast Conference Call Discussing 2nd Quarter 2014 Financial Results And Corporate Update On August 12, 2014 8/4/2014 9:40:08 AM
ProSensa Holding N.V. (RNA) Files F-3 SEC Mixed Shelf Registration For Up To $150 Million 7/7/2014 1:35:19 PM
ProSensa Holding N.V. (RNA) Strengthens Its Management Team And Supervisory Board With Key Appointments 6/30/2014 7:43:57 AM
ProSensa Holding N.V. (RNA) Awarded $200,000 Research Grant From PPMD 6/27/2014 9:09:59 AM
ProSensa Holding N.V. (RNA) Completes Enrollment In Natural History Study Of Duchenne Muscular Dystrophy 6/25/2014 8:03:38 AM
ProSensa Holding N.V. (RNA)'s Hans Schikan Appointed To The Biotechnology Industry Organization (BIO)'s Emerging Companies Section Governing Board 6/24/2014 7:39:19 AM